Question 1

Does SB Investment Advisers (UK) own TXG stock?

Accepted Answer

No. SB Investment Advisers (UK) exited its TXG (10x Genomics) position in Q3 2020. Its Q2 2020 13F listed 1,639,901 shares worth $146.5M.

Question 2

How many shares of TXG does SB Investment Advisers (UK) own?

Accepted Answer

None since Q3 2020, when SB Investment Advisers (UK) exited the position. Its Q2 2020 13F listed 1,639,901 shares worth $146.5M.

Question 3

What is SB Investment Advisers (UK)'s TXG position worth?

Accepted Answer

SB Investment Advisers (UK)'s TXG position was worth $146.5M in its Q2 2020 13F, before the exit in Q3 2020.

Question 4

Is SB Investment Advisers (UK) buying or selling TXG?

Accepted Answer

In Q3 2020, SB Investment Advisers (UK) exited its entire TXG position.

Question 5

When did SB Investment Advisers (UK) first buy TXG?

Accepted Answer

SB Investment Advisers (UK) first reported TXG in its Q1 2020 13F and listed it in 2 quarterly 13F filings.